From: Prevalence of osteo-renal impairment in the Romanian HIV cohort
Characteristic | Sub-category | n (%) | Median (IQR) | Percentiles 25, 75 | Mean ± SD |
---|---|---|---|---|---|
DXA scan result (n = 51) | Normal bone mineral density | 23 (45.1) | |||
Lumbar osteopenia | 17 (33.3) | ||||
Lumbar osteoporosis | 7 (13.7) | ||||
Femoral osteopenia | 19 (37.3) | ||||
Femoral osteoporosis | 4 (7.8) | ||||
Lumbar L1-L4 DXA T-score | N/A | N/A | –0.8 ± 1.0 | ||
Left femur DXA T-score | N/A | N/A | –0.4 ± 0.8 | ||
Serum parathyroid hormone, pg/mL | 48.2 (43.6) | 27.7, 71.3 | N/A | ||
Interpretation of serum parathyroid hormone (n = 63) | Decreased (<15 pg/mL) | 5 (7.9) | |||
Normal (15–65 pg/mL) | 37 (58.7) | ||||
Increased (>65 pg/mL) | 21 (33.3) | ||||
Serum hydroxy-vitamin D, ng/mL | N/A | N/A | 18.8 ± 10.8 | ||
Interpretation of serum hydroxy-vitamin D levels (n = 63) | Deficient (<10 ng/mL) | 16 (25.4) | |||
Insufficient (10–29.9 ng/mL) | 41 (65.1) | ||||
Optimal (30–99.9 ng/mL) | 6 (9.5) | ||||
Toxic (>100 ng/mL) | 0 (0) |